Concerned by new safety data, European regulators have initiated a review of anemia drugs made by Amgen and Roche and is cooperating with Johnson & Johnson on a review of Eprex. Anemia drugs command an $11 billion market but have recently come under a cloud. Report [1]
Links:
[1] http://www.marketwatch.com/news/story/european-regulator-starts-safety-review/story.aspx?guid=%7B061FC337%2DFF01%2D4F25%2D9CDB%2DD3ADD7CA2288%7D&dist=dist_smartbrief&dist=dist_smartbrief